EXE analyst scorecard · Expand Energy
52 rating actions on EXE in the last 12 months. Of 87 price targets that resolved, 8 were reached while they stood, 74 were replaced by the same firm first, and 5 fell short at their deadline. Ratings: 92% Buy-type, 8% Hold-type, 0% Sell-type. Consensus target $123, 36% above the last close.
Checked through 2026-10-29 · last close $90.56 (2026-10-29). Rebuilt every morning.
What the Holds say: 2 Hold-type ratings on EXE in the last 12 months carried a median target +15% from the price on the day; 0% sat below it.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Overweight | 2026-10-29 | $123 | 0 | 9 | 9 | 0 of 1 |
| UBS | Buy | 2026-10-29 | $117 | 0 | 17 | 17 | 1 of 1 |
| Truist Securities | Buy | 2026-10-29 | $122 | 0 | 7 | 8 | 0 of 1 |
| Barclays | Equal-Weight | 2026-08-17 | $107 | 1 | 9 | 10 | 0 of 1 |
| Piper Sandler | Overweight | 2026-03-12 | $138 | 0 | 8 | 8 | 0 of 1 |
| Bernstein | Outperform | 2026-10-05 | $127 | 0 | 1 | 1 | — |
| William Blair | Market Perform | 2026-04-30 | — | — | — | 0 | — |
| KeyBanc | Sector Weight | 2026-04-02 | — | 0 | 2 | 3 | — |
| Citigroup | Buy | 2026-07-09 | $115 | 0 | 2 | 3 | 1 of 1 |
| Stephens & Co. | Overweight | 2026-02-18 | $146 | 1 | 3 | 4 | 0 of 1 |
| Mizuho | Outperform | 2026-10-06 | $138 | 0 | 5 | 6 | 1 of 1 |
| Raymond James | Strong Buy | 2026-10-05 | $141 | 0 | 3 | 3 | 0 of 1 |
| Jefferies | Buy | 2026-10-02 | $136 | 0 | 3 | 3 | 0 of 1 |
| Benchmark | Buy | 2026-08-12 | $109 | 0 | 2 | 2 | 0 of 1 |
| Goldman Sachs | Buy | 2026-08-26 | $113 | — | — | 0 | — |
| Johnson Rice | Accumulate | 2026-08-17 | $125 | — | — | 0 | — |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor EXE carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-29 | UBS | Buy | maintained | $90.56 | $117 | running to 2027-10-29 | +7.6% |
| 2026-10-29 | Morgan Stanley | Overweight | maintained | $90.56 | $123 | running to 2028-04-29 | +7.6% |
| 2026-10-29 | Truist Securities | Buy | maintained | $90.56 | $122 | running to 2027-10-29 | +7.6% |
| 2026-10-15 | UBS | Buy | maintained | $90.80 | $120 | replaced 2026-10-29, new $117 | -3.6% |
| 2026-10-15 | Morgan Stanley | Overweight | maintained | $90.80 | $124 | replaced 2026-10-29, new $123 | -3.6% |
| 2026-10-06 | Mizuho | Outperform | maintained | $88.23 | $138 | running to 2027-10-06 | -9.9% |
| 2026-10-05 | Raymond James | Strong Buy | maintained | $86.43 | $141 | running to 2027-10-05 | -11.7% |
| 2026-10-05 | Bernstein | Outperform | maintained | $86.43 | $127 | running to 2027-10-05 | -11.7% |
| 2026-10-05 | Truist Securities | Buy | maintained | $86.43 | $120 | replaced 2026-10-29, new $122 | -11.7% |
| 2026-10-02 | UBS | Buy | maintained | $85.52 | $122 | replaced 2026-10-15, new $120 | -13.9% |
| 2026-10-02 | Jefferies | Buy | maintained | $85.52 | $136 | running to 2027-10-02 | -13.9% |
| 2026-09-14 | UBS | Buy | maintained | $93.40 | $129 | replaced 2026-10-02, new $122 | -1.5% |
| 2026-09-09 | Raymond James | Strong Buy | maintained | $96.62 | $147 | replaced 2026-10-05, new $141 | -1.0% |
| 2026-08-26 | Goldman Sachs | Buy | maintained | $96.57 | $113 | running to 2027-08-26 | +6.7% |
| 2026-08-19 | Morgan Stanley | Overweight | maintained | $96.03 | $129 | replaced 2026-10-15, new $124 | +10.4% |
| 2026-08-17 | Johnson Rice | Buy → Accumulate | downgrade | $94.18 | $125 | running to 2027-08-17 | +6.9% |
| 2026-08-17 | Barclays | Equal-Weight | maintained | $94.18 | $107 | running to 2027-08-17 | +6.9% |
| 2026-08-12 | Benchmark | Buy | maintained | $96.28 | $109 | running to 2027-08-12 | +10.5% |
| 2026-07-30 | UBS | Buy | maintained | $92.42 | $124 | replaced 2026-09-14, new $129 | +1.4% |
| 2026-07-30 | Truist Securities | Buy | maintained | $92.42 | $121 | replaced 2026-10-05, new $120 | +1.4% |
| 2026-07-10 | UBS | Buy | maintained | $87.25 | $127 | replaced 2026-07-30, new $124 | -1.5% |
| 2026-07-10 | Truist Securities | Buy | maintained | $87.25 | $117 | replaced 2026-07-30, new $121 | -1.5% |
| 2026-07-09 | Citigroup | Buy | maintained | $88.97 | $115 | running to 2027-07-09 | +0.2% |
| 2026-06-29 | Morgan Stanley | Overweight | maintained | $87.54 | $131 | replaced 2026-08-19, new $129 | -5.8% |
| 2026-05-26 | Barclays | Overweight → Equal-Weight | downgrade | $94.55 | $110 | replaced 2026-08-17, new $107 | -2.0% |
| 2026-05-22 | Morgan Stanley | Overweight | maintained | $97.94 | $139 | replaced 2026-06-29, new $131 | +1.6% |
| 2026-04-30 | William Blair | Outperform → Market Perform | downgrade | $102.15 | — | no target | -7.0% |
| 2026-04-30 | UBS | Buy | maintained | $102.15 | $135 | replaced 2026-07-10, new $127 | -7.0% |
| 2026-04-30 | Truist Securities | Buy | reiterated | $102.15 | $134 | replaced 2026-07-10, new $117 | -7.0% |
| 2026-04-13 | UBS | Buy | maintained | $97.78 | $133 | replaced 2026-04-30, new $135 | -8.6% |
| 2026-04-09 | Truist Securities | Buy | maintained | $99.50 | $133 | replaced 2026-04-30, new $134 | -4.9% |
| 2026-04-02 | KeyBanc | Overweight → Sector Weight | downgrade | $103.89 | — | no target | -3.8% |
| 2026-03-24 | Truist Securities | Buy | initiated | $109.69 | $136 | replaced 2026-04-09, new $133 | +1.5% |
| 2026-03-16 | Barclays | Overweight | maintained | $107.71 | $127 | replaced 2026-05-26, new $110 | +3.5% |
| 2026-03-12 | Piper Sandler | Overweight | maintained | $107.83 | $138 | running to 2027-03-12 | +5.5% |
| 2026-03-05 | Benchmark | Buy | maintained | $106.67 | $124 | replaced 2026-08-12, new $109 | -1.7% |
| 2026-03-05 | Piper Sandler | Overweight | maintained | $106.67 | $136 | replaced 2026-03-12, new $138 | -1.7% |
| 2026-02-23 | UBS | Buy | maintained | $103.18 | $135 | replaced 2026-04-13, new $133 | -5.8% |
| 2026-02-23 | Barclays | Overweight | maintained | $103.18 | $125 | replaced 2026-03-16, new $127 | -5.8% |
| 2026-02-18 | Stephens & Co. | Overweight | maintained | $99.52 | $146 | running to 2027-02-18 | -0.4% |
| 2026-01-28 | Piper Sandler | Overweight | maintained | $109.66 | $137 | replaced 2026-03-05, new $136 | -1.9% |
| 2026-01-21 | Barclays | Overweight | maintained | $109.50 | $126 | replaced 2026-02-23, new $125 | +1.5% |
| 2026-01-20 | Stephens & Co. | Overweight | maintained | $104.75 | $140 | replaced 2026-02-18, new $146 | -3.7% |
| 2026-01-08 | UBS | Buy | maintained | $104.30 | $150 | replaced 2026-02-23, new $135 | -11.2% |
| 2026-01-08 | Jefferies | Buy | maintained | $104.30 | $143 | replaced 2026-10-02, new $136 | -11.2% |
| 2026-01-05 | Bernstein | Outperform | maintained | $106.82 | $144 | replaced 2026-10-05, new $127 | -13.1% |
| 2025-12-19 | Citigroup | Buy | maintained | $108.74 | $125 | replaced 2026-07-09, new $115 | -7.3% |
| 2025-12-12 | UBS | Buy | maintained | $112.79 | $154 | replaced 2026-01-08, new $150 | -5.6% |
| 2025-12-12 | Mizuho | Outperform | maintained | $112.79 | $142 | replaced 2026-10-06, new $138 | -5.6% |
| 2025-11-18 | Piper Sandler | Overweight | maintained | $117.16 | $138 | replaced 2026-01-28, new $137 | — |
| 2025-10-30 | UBS | Buy | maintained | $100.52 | $132 | replaced 2025-12-12, new $154 | — |
| 2025-10-30 | Morgan Stanley | Overweight | maintained | $100.52 | $136 | replaced 2026-05-22, new $139 | — |
Also in Nat Gas & LNG
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.